RELATED STUDY
Key Findings:
Type of Study:
Study Result: Inconclusive
Research Location(s):
Year of Pub:
Cannabinoids Studied:
Chemotype:
Terpenes Studied:
Receptors Studied:
Ligands Studied:
DOSING DETAILS 
Study Dosing Objective: Effective Dose
Established Protocol: Effective dose
Route of Administration:
Dosing Regimen: Anandamide 5mg/kg once a day
Treatment Duration: 3 days
Clinical Relevance: Anandamide showed anti-inflammatory effects on this experimental model of colitis, further suggesting that activation of the endocannabinoid system may be useful in controlling gut inflammation in patients with inflammatory bowel diseases (IBD).
Additional Notes: Pharmacokinetic Study Data, Pharmacodynamic Study Data
Citation:
